122 related articles for article (PubMed ID: 38525814)
1. Withaferin A alters the expression of microRNAs 146a-5p and 34a-5p and associated hub genes in MDA-MB-231 cells.
Shuaib M; Chaudhri S; Kumar S
Biomol Concepts; 2024 Jan; 15(1):. PubMed ID: 38525814
[TBL] [Abstract][Full Text] [Related]
2. Withaferin A mediated changes of miRNA expression in breast cancer-derived mammospheres.
Prajapati KS; Shuaib M; Gupta S; Kumar S
Mol Carcinog; 2022 Sep; 61(9):876-889. PubMed ID: 35770722
[TBL] [Abstract][Full Text] [Related]
3. Natural Steroidal Lactone Induces G1/S Phase Cell Cycle Arrest and Intrinsic Apoptotic Pathway by Up-Regulating Tumor Suppressive miRNA in Triple-Negative Breast Cancer Cells.
Shuaib M; Prajapati KS; Gupta S; Kumar S
Metabolites; 2022 Dec; 13(1):. PubMed ID: 36676955
[TBL] [Abstract][Full Text] [Related]
4. Identification of miRNAs and related hub genes associated with the triple negative breast cancer using integrated bioinformatics analysis and
Shuaib M; Prajapati KS; Singh AK; Kushwaha PP; Waseem M; Kumar S
J Biomol Struct Dyn; 2022; 40(22):11676-11690. PubMed ID: 34387138
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of miR-155-5p enhances the anti-tumor effect of cetuximab on triple-negative breast cancer cells via inducing cell apoptosis and pyroptosis.
Xu W; Song C; Wang X; Li Y; Bai X; Liang X; Wu J; Liu J
Aging (Albany NY); 2021 Jan; 13(1):228-240. PubMed ID: 33472170
[TBL] [Abstract][Full Text] [Related]
6. Suppressive role exerted by microRNA-29b-1-5p in triple negative breast cancer through SPIN1 regulation.
Drago-Ferrante R; Pentimalli F; Carlisi D; De Blasio A; Saliba C; Baldacchino S; Degaetano J; Debono J; Caruana-Dingli G; Grech G; Scerri C; Tesoriere G; Giordano A; Vento R; Di Fiore R
Oncotarget; 2017 Apr; 8(17):28939-28958. PubMed ID: 28423652
[TBL] [Abstract][Full Text] [Related]
7. Ectopic expression of tumor suppressive miR-181c-5p downregulates oncogenic Notch signaling in MDA-MB-231 cells.
Shuaib M; Kumar S
Pathol Res Pract; 2024 Jan; 253():155017. PubMed ID: 38101160
[TBL] [Abstract][Full Text] [Related]
8. An integrated approach of bioinformatic prediction and in vitro analysis identified that miR-34a targets
Hajalirezay Yazdi S; Paryan M; Mohammadi-Yeganeh S
Cell Mol Biol Lett; 2018; 23():51. PubMed ID: 30386383
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA profiling implies new markers of chemoresistance of triple-negative breast cancer.
Ouyang M; Li Y; Ye S; Ma J; Lu L; Lv W; Chang G; Li X; Li Q; Wang S; Wang W
PLoS One; 2014; 9(5):e96228. PubMed ID: 24788655
[TBL] [Abstract][Full Text] [Related]
10. Different effects of 4β-hydroxywithanolide E and withaferin A, two withanolides from Solanaceae plants, on the Akt signaling pathway in human breast cancer cells.
Wang HC; Hu HH; Chang FR; Tsai JY; Kuo CY; Wu YC; Wu CC
Phytomedicine; 2019 Feb; 53():213-222. PubMed ID: 30668401
[TBL] [Abstract][Full Text] [Related]
11. Down-regulating GRP78 reverses pirarubicin resistance of triple negative breast cancer by miR-495-3p mimics and involves the p-AKT/mTOR pathway.
Liu M; Yang J; Lv W; Wang S; Du T; Zhang K; Wu Y; Feng X
Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34935899
[TBL] [Abstract][Full Text] [Related]
12. Let-7a/cMyc/CCAT1/miR-17-5p Circuit Re-sensitizes Atezolizumab Resistance in Triple Negative Breast Cancer through Modulating PD-L1.
Selem NA; Nafae H; Manie T; Youness RA; Gad MZ
Pathol Res Pract; 2023 Aug; 248():154579. PubMed ID: 37301086
[TBL] [Abstract][Full Text] [Related]
13. A systems biology approach and in vitro experiment indicated Rapamycin targets key cancer and cell cycle-related genes and miRNAs in triple-negative breast cancer cells.
Tafti A; Shojaei S; Zali H; Karima S; Mohammadi-Yeganeh S; Mondanizadeh M
Mol Carcinog; 2023 Dec; 62(12):1960-1973. PubMed ID: 37787375
[TBL] [Abstract][Full Text] [Related]
14. miR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancer.
Li J; Lai Y; Ma J; Liu Y; Bi J; Zhang L; Chen L; Yao C; Lv W; Chang G; Wang S; Ouyang M; Wang W
BMC Cancer; 2017 Nov; 17(1):745. PubMed ID: 29126392
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic silencing of triple negative breast cancer hallmarks by Withaferin A.
Szarc Vel Szic K; Declerck K; Crans RAJ; Diddens J; Scherf DB; Gerhäuser C; Vanden Berghe W
Oncotarget; 2017 Jun; 8(25):40434-40453. PubMed ID: 28467815
[TBL] [Abstract][Full Text] [Related]
16. Invasive Breast Cancer: miR-24-2 Targets Genes Associated with Survival and Sensitizes MDA-MB-231 Cells to Berberine.
Ali M; Bamezai RNK; Singh RP
OMICS; 2023 Sep; 27(9):409-420. PubMed ID: 37669117
[TBL] [Abstract][Full Text] [Related]
17. The long noncoding RNA sONE represses triple-negative breast cancer aggressiveness through inducing the expression of miR-34a, miR-15a, miR-16, and let-7a.
Youness RA; Hafez HM; Khallaf E; Assal RA; Abdel Motaal A; Gad MZ
J Cell Physiol; 2019 Nov; 234(11):20286-20297. PubMed ID: 30968427
[TBL] [Abstract][Full Text] [Related]
18. Induced expression of miR-1250-5p exerts tumor suppressive role in triple-negative breast cancer cells.
Shuaib M; Kumar S
J Cell Biochem; 2023 Feb; 124(2):282-293. PubMed ID: 36548440
[TBL] [Abstract][Full Text] [Related]
19. Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers.
Fkih M'hamed I; Privat M; Ponelle F; Penault-Llorca F; Kenani A; Bignon YJ
Cell Oncol (Dordr); 2015 Dec; 38(6):433-42. PubMed ID: 26392359
[TBL] [Abstract][Full Text] [Related]
20. hsa-miR-34a-5p potentiates cytarabine-mediated cell cycle arrest in MDA-MB-231 cells: a novel combination therapy.
Noorolyai S; Baghbani E; Rahmani S; Shadbad MA; Montazami N; Jigari-Asl F; Vazirabad AF; Baradaran B
Pathol Res Pract; 2022 Aug; 236():154004. PubMed ID: 35834883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
